WallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules

01 THE MACHINE READ

WHY IT MATTERS.

An at-the-market priced direct offering plus private placement dilutes existing holders of a small biotech and signals financing need.

02 THE STORY SO FAR

THE RECORD, IN ORDER.

STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.

03 WHO'S INVOLVED

ENTITIES ON FILE.

04 RECEIPTS

THE SOURCE RECORD.

05 PROPAGATION

WHAT THIS TOUCHES.